Failing Up

Failing UpIssue #6 of “What’s Her Problem?”: Step therapy purports to save patients and insurers money, but it frequently puts patients at risk.Each issue of "What's Her Problem?" includes questions for further discussion. You can Leave a Comment publicly below, or become a Paid Subscriber on Substack to join the conversation in the private community Chat.This week’s question:Have you participated in a step therapy program (knowingly or unknowingly)? Were there any adverse effects to your health as a result?Links and References:https://steptherapy.com/wp-content/uploads/2023/07/Flyer-Safe-Step-Act.pdfhttps://steptherapy.com/step-therapy-legislation-by-state/https://dawnlevitt.substack.com/p/pill-rhymes-with-kill-for-a-reason?r=heamx&utm_campaign=post&utm_medium=web&triedRedirect=truehttps://www.healthinsurance.org/glossary/step-therapy/Shan DM, Greenzaid JD, Greene E, Feldman SR. Analyzing the Benefits and Costs of the Safe Step Act on Patients, Physicians, and Insurers. J Psoriasis Psoriatic Arthritis. 2024 Jul;9(3):115-120. doi: 10.1177/24755303241253203. Epub 2024 May 7. PMID: 39301213; PMCID: PMC11361492.https://www.neurology.org/doi/pdfdirect/10.1212/CPJ.0000000000000208 /https://doi.org/10.1212/CPJ.0000000000000208 Bourdette, D. N., Hartung, D. M., & Whitham, R. H. (2016). Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patients. Neurology. Clinical Practice, 6(2), 177–182.https://www.aan.com/siteassets/home-page/conferences-and-community/regional-conferences/neurology-on-the-hill/participant-page/24-step-therapy-talking-points-premium-data.pdf This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit whatsherproblem.substack.com/subscribe